Mercado global de diagnóstico de sépsis – Tendências do setor e previsão para 2029

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado global de diagnóstico de sépsis – Tendências do setor e previsão para 2029

  • Healthcare
  • Publish Reports
  • Mar 2022
  • Global
  • 350 Páginas
  • Número de tabelas: 109
  • Número de figuras: 57

Global Sepsis Diagnostics Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Diagram Período de previsão
2020 –2029
Diagram Tamanho do mercado (ano base )
US$ MILHÕES
Diagram Tamanho do mercado ( Ano de previsão)
USD 16.53 Billion
Diagram CAGR
%
Diagram Principais participantes do mercado
  • Trinity Biotech
  • Meridian Bioscience
  • Omega Diagnostics Group PLC
  • Xcyton Diagnostics Limited
  • Diasorin S.p.A

>Mercado global de diagnóstico de sépsis , por técnicas (imunoensaio, diagnóstico molecular , microbiologia e citometria de fluxo), tipo de testetestes laboratoriais e testes de ponto de atendimento ) tendências da indústria e previsão para 2029.

Mercado de diagnóstico de sépsis

Análise e insights do mercado global: Mercado global de diagnóstico de sépsis

A sépsis é uma condição potencialmente fatal que ocorre quando a resposta do organismo a uma infeção danifica os seus próprios tecidos. Quando os processos de combate às infeções ativam o organismo, fazem com que os órgãos funcionem de forma inadequada e anormal. A sépsis pode evoluir para choque séptico. Esta é uma queda dramática da pressão arterial que pode levar a problemas graves de órgãos e à morte. Para ser diagnosticado com sépsis é necessário confirmar a infeção com sinais como alteração do estado mental, pressão arterial sistólica, frequência respiratória. Na maioria das vezes, a sépsis ocorre em pessoas hospitalizadas ou que foram recentemente hospitalizadas. As pessoas internadas em unidades de cuidados intensivos têm maior probabilidade de desenvolver infeções que podem levar à sépsis. Para o diagnóstico de sépsis, juntamente com análises ao sangue, é necessário realizar outros exames laboratoriais. As amostras de sangue são utilizadas para testar evidências de infeção, problemas de coagulação, função hepática ou renal anormal, disponibilidade de oxigénio deficiente, desequilíbrios eletrolíticos. As pessoas com sépsis necessitam de monitorização e tratamento rigorosos numa unidade de cuidados intensivos hospitalar. Podem ser necessárias medidas de salvamento para estabilizar a respiração e a função cardíaca.

A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 8,0% no período de previsão de 2022 a 2029.

Métrica de reporte

Detalhes

Período de previsão

2022 a 2029

Ano base

2021

Anos históricos

2019-2020 (personalizável para 2019 - 2014)

Unidades Quantitativas

Receita em milhões de dólares, volumes em unidades, preços em dólares

Segmentos cobertos

Por técnicas (imunoensaio, diagnóstico molecular, microbiologia e citometria de fluxo), tipo de teste (testes laboratoriais e testes no local de atendimento)

Países abrangidos

EUA e Resto da América do Norte na América do Norte, Alemanha, França, Reino Unido e Resto da Europa na Europa, China, Japão, Índia, Coreia do Sul, Singapura, Malásia, Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia -Pacífico (APAC ) na Ásia-Pacífico (APAC), Brasil e Resto da América do Sul como parte da América do Sul. África do Sul, Arábia Saudita e Resto do Médio Oriente e África (MEA) como parte do Médio Oriente e África (MEA).

Participantes do mercado abrangidos

The major companies which are dealing in the market are Trinity Biotech (Ireland), Meridian Bioscience (U.S.), Omega Diagnostics Group PLC. (U.K.), Xcyton Diagnostics Limited (india), Diasorin S.p.A (Italy), Seegene Inc. (South Korea), EKF Diagnostics Holdings plc (U.K.), Axis-Shield Diagnostics Ltd. (U.K.), Immunexpress Inc. (U.S.), Luminex Corporation (U.S.), bioMérieux SA (France), BD (U.S.), Thermo Fisher Scientific Inc.(U.S.), Abbott (U.S), Roche Diagnostics (U.S), Cepheid (U.S.), Beckman Coulter, Inc. (U.S.), T2 Biosystems, Inc. (U.S.), Bruker (U.S.) and Ortho Clinical Diagnostics (U.S.).

Sepsis Diagnostics Market Dynamics

Drivers

  • Rising incidence of hospital-acquired infections

With the rapid increase in HAIs worldwide, there is an increase in the demand for proper sepsis diagnostic products will increase in upcoming years. Therefore, rising incidences of hospital-acquired infections are expected to act as a driver for the growth of the sepsis diagnostics market.

  • Rising healthcare expenditure

Another significant factor influencing the growth rate of sepsis diagnostics market is the rising healthcare expenditure which helps in improving its infrastructure.

  • Growing prevalence of sepsis

Growing prevalence of sepsis in various regions worldwide and various infections associated with it are expected to act as drivers for the growth of the sepsis diagnostics market

Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the sepsis diagnostics market.

Opportunities

  • Evolution of novel biomarkers for sepsis diagnosis

Sepsis is one of the leading causes of mortality and morbidity, even with the current availability of extended-spectrum antibiotics and advanced medical care. Biomarkers offer a tool in facilitating early diagnosis, in identifying patient populations at high risk of complications, and in monitoring the progression of the disease, which are critical assessments for appropriate therapy and improvement in patient outcomes.

Also, the launch of effective therapies and continuous clinical trials will provide beneficial opportunities for the sepsis diagnostics market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate sepsis diagnostics market in future.

Restraints/Challenges

However, high cost of diagnosis and lack of appropriate testing for sepsis will impede the growth rate of sepsis diagnostics market. Additionally, lack of awareness about sepsis will further challenge the market in the forecast period mentioned above.

Este relatório de mercado de diagnóstico de sépsis fornece detalhes de novos desenvolvimentos recentes, regulamentos comerciais, análise de importação-exportação, análise de produção, otimização da cadeia de valor, quota de mercado, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações no mercado regulamentações, análise estratégica de crescimento de mercado, tamanho de mercado, crescimento de mercado de categoria, nichos de aplicação e domínio, aprovações de produtos, lançamentos de produtos, expansões geográficas, inovações tecnológicas no mercado . Para mais informações sobre o mercado de diagnóstico de sépsis, contacte a Data Bridge Market Research para obter um resumo do analista , a nossa equipa irá ajudá-lo a tomar uma decisão de mercado informada para alcançar o crescimento do mercado.

Impacto pós-COVID-19 no mercado de diagnóstico de sépsis

O COVID-19 afetou negativamente o mercado. Os bloqueios e o isolamento durante as pandemias complicam a gestão da doença e a adesão à medicação. A falta de acesso a instalações de saúde para tratamento de rotina e administração de medicamentos irá afectar ainda mais o mercado. O isolamento social aumenta o stress, o desespero e o apoio social, o que pode provocar uma redução da adesão aos medicamentos para a sépsis durante a pandemia.

Desenvolvimento recente

  • Em maio de 2020, a Beckman Coulter anunciou a disponibilidade do seu analisador hematológico DxH 690T nos EUA, que é utilizado como indicador precoce de sépsis. Este anúncio ajudou a empresa a aumentar a sua presença global e também o crescimento das receitas.

Mercado de diagnóstico de sépsisÂmbito global do mercado de diagnóstico de sépsis

O mercado global de diagnóstico de sépsis está segmentado em técnicas e tipos de testes. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e a fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para tomar decisões estratégicas para identificar as principais aplicações do mercado.

Técnicas

  • Imunoensaio
  • Diagnóstico Molecular
  • Microbiologia
  • Citometria de Fluxo

Com base em técnicas, o mercado global de diagnóstico de sépsis está segmentado em microbiologia, diagnóstico molecular, imunoensaio e citometria de fluxo.

Tipo de teste

  • Testes de Laboratório
  • Teste no ponto de atendimento

Com base no tipo de teste, o mercado global de diagnóstico de sépsis está segmentado em testes laboratoriais e testes no local de atendimento.

Mercado de diagnóstico de sépsis

Análise/perspetivas regionais            do mercado de diagnóstico de sépsis

O mercado de diagnóstico de sépsis é analisado e são fornecidos insights e tendências do tamanho do mercado por país, técnicas e tipo de teste, conforme mencionado acima.

Os países abrangidos no relatório de mercado de diagnóstico de sépsis são os EUA, resto da América do Norte, Alemanha, Reino Unido, França, resto da Europa, China, Índia, Japão, Coreia do Sul, Austrália, Singapura, Tailândia, Malásia, Indonésia , Filipinas, resto do Ásia-Pacífico, Brasil, Resto da América do Sul, Arábia Saudita, África do Sul, resto do Médio Oriente e África.

North America dominates the sepsis diagnostics market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region combined with rising number of the adult population getting diagnosed positive for sepsis, each year in the region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing healthcare expenditure by the government of developing nations and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Sepsis Diagnostics Market Share Analysis

The sepsis diagnostics market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on sepsis diagnostics market.

Some of the major players operating in the sepsis diagnostics market are Trinity Biotech (Ireland), Meridian Bioscience, Omega Diagnostics Group PLC., Xcyton Diagnostics Limited, Diasorin S.p.A, Seegene Inc., EKF Diagnostics Holdings plc., Axis-Shield Diagnostics Ltd., Immunexpress Inc., Luminex Corporation, bioMérieux SA, BD, Thermo Fisher Scientific Inc. Abbott, Roche Diagnostics, Cepheid, Beckman Coulter, Inc., T2 Biosystems, Inc., and Bruker Ortho Clinical Diagnostics among others.

Research Methodology: Global Sepsis Diagnostics Market

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Além disso, os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise da quota de mercado da empresa, padrões de medição, análise global vs. regional e de participação dos fornecedores. Solicite a chamada do analista em caso de dúvidas adicionais.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL SEPSIS DIAGNOSTICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TECHNIQUES LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET TECHNIQUES COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISE IN INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS

5.1.2 RISE IN HEALTHCARE EXPENDITURE

5.1.3 GROW IN PREVALENCE OF SEPSIS

5.1.4 RISE IN TECHNOLOGICAL ADVANCEMENTS OF SEPSIS DIAGNOSTIC DEVICES

5.2 RESTRAINTS

5.2.1 HIGH COST OF DIAGNOSIS

5.2.2 LACK OF APPROPRIATE TESTING FOR SEPSIS

5.3 OPPORTUNITIES

5.3.1 DEVELOPMENT OF RAPID DIAGNOSTIC/POINT OF CARE (POC) TECHNIQUES FOR EARLY SEPSIS DIAGNOSIS

5.3.2 EVOLUTION OF NOVEL BIOMARKERS FOR SEPSIS DIAGNOSIS

5.4 CHALLENGES

5.4.1 LACK OF AWARENESS ABOUT SEPSIS

5.4.2 SHORTAGE OF SKILLED HEALTHCARE PROFESSIONALS

6 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES

6.1 OVERVIEW

6.2 IMMUNOASSAY

6.2.1 PROCALCITONIN (PCT)

6.2.2 INTERLEUKIN-6 (IL-6)

6.2.3 C-REACTIVE PROTEIN (CRP)

6.2.4 PENTRAXIN-3 (PTX3)

6.2.5 CALPROTECTIN

6.2.6 OTHERS

6.3 MOLECULAR DIAGNOSTIC

6.4 MICROBIOLOGY

6.5 FLOW CYTOMETRY

7 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE

7.1 OVERVIEW

7.2 LABORATORY TESTING

7.3 POINT OF CARE TESTING

8 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION

8.1 OVERVIEW

8.2 NORTH AMERICA

8.2.1 OVERVIEW

8.2.2 U.S.

8.2.3 REST OF NORTH AMERICA

8.3 EUROPE

8.3.1 OVERVIEW

8.3.2 GERMANY

8.3.3 U.K.

8.3.4 FRANCE

8.3.5 REST OF EUROPE

8.4 ASIA-PACIFIC

8.4.1 OVERVIEW

8.4.2 CHINA

8.4.3 INDIA

8.4.4 JAPAN

8.4.5 SOUTH KOREA

8.4.6 AUSTRALIA

8.4.7 SINGAPORE

8.4.8 THAILAND

8.4.9 MALAYSIA

8.4.10 INDONESIA

8.4.11 PHILIPPINES

8.4.12 REST OF ASIA-PACIFIC

8.5 SOUTH AMERICA

8.5.1 OVERVIEW

8.5.2 BRAZIL

8.5.3 REST OF SOUTH AMERICA

8.6 MIDDLE EAST AND AFRICA

8.6.1 OVERVIEW

8.6.2 SOUTH AFRICA

8.6.3 SAUDI ARABIA

8.6.4 REST OF MIDDLE EAST AND AFRICA

9 GLOBAL SEPSIS DIAGNOSTICS MARKET: COMPANY LANDSCAPE

9.1 COMPANY SHARE ANALYSIS: GLOBAL

9.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

9.3 COMPANY SHARE ANALYSIS: EUROPE

9.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

10 COMPANY PROFILE

10.1 ROCHE DIAGNOSTICS

10.1.1 COMPANY SNAPSHOT

10.1.2 REVENUE ANALYSIS

10.1.3 COMPANY SHARE ANALYSIS

10.1.4 PRODUCT PORTFOLIO

10.1.5 RECENT DEVELOPMENT

10.2 ABBOTT.

10.2.1 COMPANY SNAPSHOT

10.2.2 REVENUE ANALYSIS

10.2.3 COMPANY SHARE ANALYSIS

10.2.4 PRODUCT PORTFOLIO

10.2.5 RECENT DEVELOPMENT

10.2.5.1 PRODUCT LAUNCH

10.3 BIOMERIEUX SA

10.3.1 COMPANY SNAPSHOT

10.3.2 REVENUE ANALYSIS

10.3.3 COMPANY SHARE ANALYSIS

10.3.4 PRODUCT PORTFOLIO

10.3.5 RECENT DEVELOPMENT

10.3.5.1 PRODUCT LAUNCH

10.4 THERMO FISHER SCINETIFIC INC.

10.4.1 COMPANY SNAPSHOT

10.4.2 REVENUE ANALYSIS

10.4.3 COMPANY SHARE ANALYSIS

10.4.4 PRODUCT PORTFOLIO

10.4.5 RECENT DEVELOPMENT

10.4.5.1 ACQUISITION

10.5 BD

10.5.1 COMPANY SNAPSHOT

10.5.2 REVENUS ANALYSIS

10.5.3 COMPANY SHARE ANALYSIS

10.5.4 PRODUCT PORTFOLIO

10.5.5 RECENT DEVELOPMENT

10.6 SEEGENE INC.

10.6.1 COMPANY SNAPSHOT

10.6.2 REVENUE ANALYSIS

10.6.3 PRODUCT PORTFOLIO

10.6.4 RECENT DEVELOPMENT

10.7 AXIS-SHIELD DIAGNOSTICS LTD.

10.7.1 COMPANY SNAPSHOT

10.7.2 PRODUCT PORTFOLIO

10.7.3 RECENT DEVELOPMENTS

10.8 BECKMAN COULTER, INC.

10.8.1 COMPANY SNAPSHOT

10.8.2 PRODUCT PORTFOLIO

10.8.3 RECENT DEVELOPMENTS

10.9 BRUKER

10.9.1 COMPANY SNAPSHOT

10.9.2 REVENUS ANALYSIS

10.9.3 PRODUCT PORTFOLIO

10.9.4 RECENT DEVELOPMENTS

10.1 CEPHEID

10.10.1 COMPANY SNAPSHOT

10.10.2 REVENUE ANALYSIS

10.10.3 PRODUCT PORTFOLIO

10.10.4 RECENT DEVELOPMENT

10.10.4.1 PROGRAM LAUNCH

10.11 DIASORIN S.P.A.

10.11.1 COMPANY SNAPSHOT

10.11.2 REVENUE ANALYSIS

10.11.3 PRODUCT PORTFOLIO

10.11.4 RECENT DEVELOPMENT

10.11.4.1 ACQUISITION

10.12 EKF DIAGNOSTICS HOLDINGS PLC

10.12.1 COMPANY SNAPSHOT

10.12.2 REVENUE ANALYSIS

10.12.3 PRODUCT PORTFOLIO

10.12.4 RECENT DEVELOPMENT

10.12.4.1 ACQUISITION

10.13 IMMUNEXPRESS INC.

10.13.1 COMPANY SNAPSHOT

10.13.2 PRODUCT PORTFOLIO

10.13.3 RECENT DEVELOPMENT

10.13.3.1 PRODUCT LAUNCH

10.14 LUMINEX CORPORATION.

10.14.1 COMPANY SNAPSHOT

10.14.2 PRODUCT PORTFOLIO

10.14.3 RECENT DEVELOPMENT

10.14.3.1 ACQUISITION

10.15 MERIDIAN BIOSCIENCE

10.15.1 COMPANY SNAPSHOT

10.15.2 REVENUS ANALYSIS

10.15.3 PRODUCT PORTFOLIO

10.15.4 RECENT DEVELOPMENTS

10.16 OMEGA DIAGNOSTICS GROUP PLC

10.16.1 COMPANY SNAPSHOT

10.16.2 REVENUE ANALYSIS

10.16.3 PRODUCT PORTFOLIO

10.16.4 RECENT DEVELOPMENT

10.17 ORTHO CLINICAL DIAGNOSTICS.

10.17.1 COMPANY SNAPSHOT

10.17.2 REVENUE ANALYSIS

10.17.3 PRODUCT PORTFOLIO

10.17.4 RECENT DEVELOPMENT

10.17.4.1 PRODUCT LAUNCH

10.18 T2 BIOSYSTEM, INC.

10.18.1 COMPANY SNAPSHOT

10.18.2 PRODUCT PORTFOLIO

10.18.3 RECENT DEVELOPMENT

10.18.3.1 PRODUCT LAUNCH

10.19 TRINITY BIOTECH

10.19.1 COMPANY SNAPSHOT

10.19.2 REVENUE ANALYSIS

10.19.3 PRODUCT PORTFOLIO

10.19.4 RECENT DEVELOPMENT

10.2 XCTON DAGNOSTICS LIMITED

10.20.1 COMPANY SNAPSHOT

10.20.2 PRODUCT PORTFOLIO

10.20.3 RECENT DEVELOPMENT

11 QUESTIONNAIRE

12 RELATED REPORTS

Lista de Tabela

TABLE 1 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 2 GLOBAL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)

TABLE 3 GLOBAL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 4 GLOBAL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)

TABLE 6 GLOBAL MICROBIOLOGY IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)

TABLE 7 GLOBAL FLOW CYTOMETRY IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)

TABLE 8 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 9 GLOBAL LABORATORY TESTING IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)

TABLE 10 GLOBAL POINT OF CARE TESTING IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)

TABLE 11 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)

TABLE 12 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)

TABLE 13 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 14 NORTH AMERICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 15 NORTH AMERICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 16 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 17 U.S. SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 18 U.S. IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 19 U.S. IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 20 U.S. SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 21 REST OF NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 22 EUROPE SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)

TABLE 23 EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 24 EUROPE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 25 EUROPE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 26 EUROPE SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 27 GERMANY SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 28 GERMANY IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 29 GERMANY IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 30 GERMANY SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 31 U.K. SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 32 U.K. IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 33 U.K. IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 34 U.K. SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 35 FRANCE SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 36 FRANCE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 37 FRANCE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 38 FRANCE SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 39 REST OF EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 40 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)

TABLE 41 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 42 ASIA-PACIFIC IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 43 ASIA-PACIFIC IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 44 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 45 CHINA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 46 CHINA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 47 CHINA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 48 CHINA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 49 INDIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 50 INDIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 51 INDIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 52 INDIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 53 JAPAN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 54 JAPAN IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 55 JAPAN IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 56 JAPAN SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 57 SOUTH KOREA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 58 SOUTH KOREA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 59 SOUTH KOREA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 60 SOUTH KOREA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 61 AUSTRALIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 62 AUSTRALIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 63 AUSTRALIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 64 AUSTRALIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 65 SINGAPORE SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 66 SINGAPORE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 67 SINGAPORE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 68 SINGAPORE SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 69 THAILAND SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 70 THAILAND IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 71 THAILAND IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 72 THAILAND SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 73 MALAYSIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 74 MALAYSIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 75 MALAYSIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 76 MALAYSIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 77 INDONESIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 78 INDONESIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 79 INDONESIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 80 INDONESIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 81 PHILIPPINES SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 82 PHILIPPINES IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 83 PHILIPPINES IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 84 PHILIPPINES SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 85 REST OF ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 86 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)

TABLE 87 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 88 SOUTH AMERICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 89 SOUTH AMERICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 90 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 91 BRAZIL SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 92 BRAZIL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 93 BRAZIL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 94 BRAZIL SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 95 REST OF SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 96 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)

TABLE 97 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 98 MIDDLE EAST AND AFRICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 99 MIDDLE EAST AND AFRICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 100 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 101 SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 102 SOUTH AFRICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 103 SOUTH AFRICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 104 SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 105 SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 106 SAUDI ARABIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

TABLE 107 SAUDI ARABIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)

TABLE 108 SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)

TABLE 109 REST OF MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)

Lista de Figura

FIGURE 1 GLOBAL SEPSIS DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 GLOBAL SEPSIS DIAGNOSTICS MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL SEPSIS DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL SEPSIS DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL SEPSIS DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL SEPSIS DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL SEPSIS DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL SEPSIS DIAGNOSTICS MARKET: MARKET TECHNIQUES COVERAGE GRID

FIGURE 9 GLOBAL SEPSIS DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL SEPSIS DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 11 THE GROWING PREVALENCE OF SEPSIS IS EXPECTED TO DRIVE THE GLOBAL SEPSIS DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 TECHNIQUES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL SEPSIS DIAGNOSTICS MARKET IN 2022 & 2029

FIGURE 13 NORTH AMERICA TO DOMINATE AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE GLOBAL SEPSIS DIAGNOSTICS MARKET FROM 2022 TO 2029

FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR SEPSIS DIAGNOSTICS MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGES FOR THE GLOBAL SEPSIS DIAGNOSTICS MARKET

FIGURE 16 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES, 2021

FIGURE 17 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES, 2022-2029 (USD MILLION)

FIGURE 18 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES, CAGR (2022-2029)

FIGURE 19 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES, LIFELINE CURVE

FIGURE 20 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TEST TYPE, 2021

FIGURE 21 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TEST TYPE, 2022-2029 (USD MILLION)

FIGURE 22 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2022-2029)

FIGURE 23 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 24 GLOBAL SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)

FIGURE 25 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY REGION (2021)

FIGURE 26 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY REGION (2022 & 2029)

FIGURE 27 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY REGION (2021 & 2029)

FIGURE 28 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)

FIGURE 29 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)

FIGURE 30 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)

FIGURE 31 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 32 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 33 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)

FIGURE 34 EUROPE SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)

FIGURE 35 EUROPE SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)

FIGURE 36 EUROPE SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 37 EUROPE SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 38 EUROPE SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)

FIGURE 39 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)

FIGURE 40 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)

FIGURE 41 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 42 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 43 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)

FIGURE 44 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)

FIGURE 45 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)

FIGURE 46 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 47 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 48 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)

FIGURE 49 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)

FIGURE 50 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)

FIGURE 51 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 52 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 53 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)

FIGURE 54 GLOBAL SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)

FIGURE 55 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)

FIGURE 56 EUROPE SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)

FIGURE 57 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The market is segmented based on , By Techniques (Immunoassay, Molecular Diagnostic, Microbiology & Flow Cytometry), Test Type (Laboratory Testing & Point of Care Testing) Industry Trends and Forecast to 2029. .
The Global Sepsis Diagnostics Market size was valued at USD 0.00 USD Billion in 2019.
The Global Sepsis Diagnostics Market is projected to grow at a CAGR of 8% during the forecast period of 2020 to 2029.
The major players operating in the market include Trinity Biotech, Meridian Bioscience, Omega Diagnostics Group PLC, Xcyton Diagnostics Limited, Diasorin S.p.A, Seegene , EKF Diagnostics Holdings plc, Axis-Shield Diagnostics , Immunexpress , Luminex Corporation, bioMérieux SA, BD, Thermo Fisher Scientific , Abbott, Roche Diagnostics, Cepheid, Beckman Coulter , T2 Biosystems , Bruker, Ortho Clinical Diagnostics,.
The market report covers data from the U.S. and Rest of North America in North America, Germany, France, U.K. and Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Brazil and Rest of South America as part of South America. South Africa, Saudi Arabia and Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)..